⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 13, 2015SLAS DISCOVERYOpen Access

A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

BFBernard FerminiTexas Tech University JHJules C. HancoxElectrophysiology NANajah Abi‐GergesAnaBios (United States)

Discussion

Loading...

Member takes

Implication

Supports CiPA exploration to reduce QT attrition costs; leaves open regulatory adoption pending validation.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fermini et al. (2015) studied this question.

synapsesocial.com/papers/6a70b479f44fa9f079de64cf https://doi.org/10.1177/1087057115594589

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Utility of hERG Assays as Surrogate Markers of Delayed Cardiac Repolarization and QT Safety2006 · 87 citations
2Early identification of hERG liability in drug discovery programs by automated patch clamp2014 · 108 citations
3Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy2004 · 58 citations
4High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents2011 · 806 citations
5Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes2011 · 157 citations